Literature DB >> 733425

Current status of mumps and mumps vaccine in the United States.

G F Hayden, S R Preblud, W A Orenstein, J L Conrad.   

Abstract

Reported mumps in the United States has declined to all-time low levels following the increasingly widespread use of mumps-virus vaccine. Mumps vaccine has proven safe and effective. Its incorporation into combined live-virus vaccines, especially measles-mumps-rubella, has made mumps vaccination a practical and economically feasible component of routine immunization activities. Because of the favorable experience to date with mumps vaccine and the associated drop in mumps morbidity and mortality, mumps control programs likely will receive increasing public health attention in the coming years.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 733425

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Mumps, measles, and rubella vaccination and encephalitis.

Authors:  S Crowley; S T al-Jawad; I Z Kovar
Journal:  BMJ       Date:  1989-09-09

2.  Epidemic of mumps in a partially immune population.

Authors:  J E Lewis; M A Chernesky; M L Rawls; W E Rawls
Journal:  Can Med Assoc J       Date:  1979-09-22       Impact factor: 8.262

3.  Unilateral deafness as a complication of the mumps, measles, and rubella vaccination.

Authors:  J Nabe-Nielsen; B Walter
Journal:  BMJ       Date:  1988-08-13

4.  Assessing clinical trials--design I.

Authors:  S M Gore
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

Review 5.  Mumps and varicella vaccines.

Authors:  J A Dudgeon
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

6.  Prevention of mumps.

Authors:  J Desmyter
Journal:  Br Med J       Date:  1980-12-13

7.  Prevention of mumps.

Authors: 
Journal:  Br Med J       Date:  1980-11-08

8.  Chapter 8 Paramyxoviruses.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29

Review 9.  A review of vaccine effects on women in light of the COVID-19 pandemic.

Authors:  Wen-Han Chang
Journal:  Taiwan J Obstet Gynecol       Date:  2020-09-11       Impact factor: 1.705

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.